Skip to Main Content
Skip Nav Destination

Pimavanserin (Nuplazid™) for the treatment of Parkinson disease psychosis: A review of the literature

Mental Health Clinician (2017) 7 (5): 230–234.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • J. Bradley Layton
  • Joan Forns
  • Lisa J. McQuay
  • Heather E. Danysh
  • Colleen Dempsey
  • Mary S. Anthony
  • Mary Ellen Turner
Drug Safety (2023) 46 (2): 195.
  • MRINALINI C. DAMLE
  • ROSHANI R. PARDESHI
  • SHUBHANGI R. BIDKAR
International Journal of Pharmacy and Pharmaceutical Sciences 17.
  • Beatrice Heim
  • Marina Peball
  • Florian Krismer
  • Atbin Djamshidian
  • Klaus Seppi
Neuropsychiatric Disease and Treatment (2023) Volume 19: 1303.
  • Matthew Remz
  • Meagen Salinas
Psychiatric Annals (2020) 50 (3): 113.
  • Sarah Goldsborough
Mental Health Clinician (2018) 8 (4): 198.
  • Sarah Schubmehl
  • Joleen Sussman
The American Journal of Geriatric Psychiatry (2018) 26 (10): 1007.
Close Modal

or Create an Account

Close Modal
Close Modal